Press "Enter" to skip to content

New patent for Teva Pharm drug AIRDUO RESPICLICK

0
Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug AIRDUO RESPICLICK

Annual Drug Patent Expirations for AIRDUO+RESPICLICK
Annual Drug Patent Expirations for AIRDUO+RESPICLICK

Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from four suppliers. There are sixteen patents protecting this drug.

Drug patent litigation for AIRDUO RESPICLICK.

The generic ingredient in AIRDUO RESPICLICK is fluticasone propionate; salmeterol xinafoate. Four suppliers are listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug AIRDUO RESPICLICK
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions